IRIS
PICCHIO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.643
NA - Nord America 1.206
AS - Asia 672
OC - Oceania 19
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
Totale 3.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.180
SE - Svezia 804
SG - Singapore 349
IT - Italia 342
CN - Cina 259
RU - Federazione Russa 248
FI - Finlandia 66
IE - Irlanda 45
DE - Germania 43
CA - Canada 20
AU - Australia 19
PL - Polonia 18
FR - Francia 17
GB - Regno Unito 17
NL - Olanda 16
IR - Iran 13
IN - India 10
HK - Hong Kong 8
JP - Giappone 8
TR - Turchia 7
BE - Belgio 6
EU - Europa 6
BR - Brasile 5
UA - Ucraina 5
CZ - Repubblica Ceca 4
GR - Grecia 4
ID - Indonesia 4
MX - Messico 4
IL - Israele 3
BG - Bulgaria 2
CL - Cile 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
JM - Giamaica 1
LV - Lettonia 1
MA - Marocco 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.559
Salva come PNG Salva come JPEG
Città #
Lawrence 244
Princeton 244
Singapore 221
Milan 183
Ashburn 134
Shanghai 119
New York 90
Moscow 71
Boardman 64
Helsinki 59
Dublin 45
West Jordan 22
Dallas 20
Rome 18
Washington 18
Seattle 17
Los Angeles 11
Beijing 9
London 9
Santa Clara 9
Warsaw 9
Lappeenranta 7
Philadelphia 7
Shenzhen 7
Brussels 6
Canberra 6
Toronto 6
Adelaide 5
Falls Church 5
Guangzhou 5
Hamilton 5
Jiaxing 5
Lublin 5
Naples 5
Pune 5
Wuxi 5
Amsterdam 4
Andover 4
Athens 4
Goito 4
Gustavo Adolfo Madero 4
Hangzhou 4
Hong Kong 4
Leytonstone 4
Montecchio Maggiore 4
Pesaro 4
Xi'an 4
Bandung 3
Borås 3
Chiusi 3
Genoa 3
Hanover 3
Lissone 3
Naaldwijk 3
Oshnaviyeh 3
Palermo 3
Sarno 3
Secaucus 3
St Petersburg 3
Sydney 3
Tel Aviv 3
Tokyo 3
Varese 3
Winnipeg 3
Airdrie 2
Aprilia 2
Arzano 2
Brescia 2
Brisbane 2
Brooklyn 2
Buffalo 2
Campinas 2
Cologno Monzese 2
Council Bluffs 2
Engelhard 2
Fairburn 2
Foshan 2
Frankfurt am Main 2
Fuzhou 2
Gatineau 2
Groningen 2
Jena 2
Kashan 2
Lodi 2
Meppel 2
Mountain View 2
Munich 2
Nuremberg 2
Paris 2
Parma 2
Pescara 2
Pessac 2
Pisa 2
Porto Alegre 2
Prague 2
Razgrad 2
Riyadh 2
Rockville 2
Rzeszów 2
Sainte-Foy-les-Lyon 2
Totale 1.867
Salva come PNG Salva come JPEG
Nome #
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 62
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 59
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 52
11C-choline PET/CT and PSA kinetics 50
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 49
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 46
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 44
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 43
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 43
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 36
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 35
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 35
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 34
Nuclear medicine in prostate cancer management 33
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 33
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 31
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 30
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 30
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 30
18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study 29
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 29
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 29
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 29
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 29
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 29
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience 28
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment 27
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 27
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 27
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 27
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 26
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 26
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 26
[C-11]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 26
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 26
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 26
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 26
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 25
[F-18]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients 25
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 25
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 25
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 24
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 24
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 24
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 23
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 23
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 23
PET/MRI and prostate cancer 22
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 22
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 22
Increased Choline Uptake in Bronchioalveolar Cell Carcinoma with Negative FDG Uptake. A PET/CT and Pathology Study 22
FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease 22
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 22
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 21
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 21
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 21
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 21
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 20
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 20
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 20
18F-FDG positron emission tomography compared with computed tomography in diagnosing recurrent ovarian carcinoma 19
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 19
First evaluation of PET-based human bioDistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia 19
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 19
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 19
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 19
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY 18
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 18
Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT 18
DETECTION OF BONE METASTASES AND EVALUATION OF THERAPY RESPONSE IN PROSTATE CANCER PATIENTS BY RADIOLABELLED CHOLINE PET/CT 18
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 17
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 17
Diagnosis of local recurrence after radical prostatectomy 17
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 17
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 17
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 17
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 16
CRITICAL ASSESSMENT OF THE PERFORMANCE OF PSA KINETICS FOR THE PREDICTION OF [11C]CHOLINE PET/CT IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 16
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 16
68Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis 16
The Authors Reply 16
Re: Daniel E. Spratt, Herbert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71;37–43: High-dose Radiotherapy and Pelvic Lymph Nodal Irradiation for High-risk Prostate Cancer in the Image-guided Radiotherapy Era 16
Hypofractionated 4D-PET/CT-based helical tomotherapy for the treatment of lung metastases: A feasibility study 16
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 15
PET/CT for radiotherapy: image acquisition and data processing 15
Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma 15
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 15
New Clinical Indications for18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature [Figure presented] 15
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 15
Defining the Right State for a Will Rogers Phenomenon in Oligometastatic Prostate Cancer 15
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 14
Radiomics and artificial intelligence 14
M. Kirienko, E. Grosso, I. Prognostic Value of pre-therapy 18FDG PET/CT for the Outcome of 18FDG PET-guided SIB-IMRT in Patients with Head and Neck Cancer 14
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 14
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 14
[18F]FDG-PET and [11C]Choline-PET uptake in different types of NSCLC: Comparison with histological and molecular data. 14
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 14
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 14
Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units 14
US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer 14
Totale 2.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 4 2 2 0 12 5 1
2020/2021116 0 0 4 69 0 36 1 2 2 1 0 1
2021/2022222 1 11 1 96 14 7 13 12 18 29 5 15
2022/20231.532 543 314 123 36 23 178 81 124 43 31 5 31
2023/20241.006 52 45 149 102 66 168 36 104 12 60 54 158
2024/2025920 529 66 66 99 141 19 0 0 0 0 0 0
Totale 3.954